世界の脳転移治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Brain Metastasis Therapeutic Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3932 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、脳転移治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、抗けいれん薬、標的療法、化学療法、放射線療法）、用途別市場規模（がん研究センター、がん病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・脳転移治療の市場動向 ・企業の競争状況、市場シェア ・脳転移治療の種類別市場規模と予測2016-2027（コルチコステロイド、抗けいれん薬、標的療法、化学療法、放射線療法） ・脳転移治療の用途別市場規模と予測2016-2027（がん研究センター、がん病院、診療所、その他） ・脳転移治療の北米市場規模2016-2027（アメリカ、カナダ） ・脳転移治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・脳転移治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・脳転移治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・脳転移治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（F. Hoffmann-La Roche Ltd.、GlaxoSmithKline、Eli Lilly & Company、Merck & Co., Inc.、Bayer AG、AngioChem Inc.、Novartis AG、Pfizer Inc.、AstraZeneca、Sanofi） ・結論

Brain metastasis is a kind of cancer. Cancers that have spread to the brain include breast cancer, lung cancer, melanoma, renal cell carcinoma, etc. Brain metastases mostly occur in the brain, and can be effectively relieved by chemotherapy, radiation therapy and other treatment methods.

Market Analysis and Insights: Global Brain Metastasis Therapeutic Market
The global Brain Metastasis Therapeutic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Brain Metastasis Therapeutic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Brain Metastasis Therapeutic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Brain Metastasis Therapeutic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Brain Metastasis Therapeutic market.

Global Brain Metastasis Therapeutic Scope and Market Size
Brain Metastasis Therapeutic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Brain Metastasis Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Corticosteroids
Anticonvulsants
Targeted Therapy
Chemotherapy
Radiation Therapy

Segment by Application
Cancer Research Centers
Cancer Hospitals
Clinics
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline
Eli Lilly & Company
Merck & Co., Inc.
Bayer AG
AngioChem Inc.
Novartis AG
Pfizer Inc.
AstraZeneca
Sanofi

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Brain Metastasis Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Corticosteroids
1.2.3 Anticonvulsants
1.2.4 Targeted Therapy
1.2.5 Chemotherapy
1.2.6 Radiation Therapy
1.3 Market by Application
1.3.1 Global Brain Metastasis Therapeutic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer Research Centers
1.3.3 Cancer Hospitals
1.3.4 Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Brain Metastasis Therapeutic Market Perspective (2016-2027)
2.2 Brain Metastasis Therapeutic Growth Trends by Regions
2.2.1 Brain Metastasis Therapeutic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Brain Metastasis Therapeutic Historic Market Share by Regions (2016-2021)
2.2.3 Brain Metastasis Therapeutic Forecasted Market Size by Regions (2022-2027)
2.3 Brain Metastasis Therapeutic Industry Dynamic
2.3.1 Brain Metastasis Therapeutic Market Trends
2.3.2 Brain Metastasis Therapeutic Market Drivers
2.3.3 Brain Metastasis Therapeutic Market Challenges
2.3.4 Brain Metastasis Therapeutic Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Brain Metastasis Therapeutic Players by Revenue
3.1.1 Global Top Brain Metastasis Therapeutic Players by Revenue (2016-2021)
3.1.2 Global Brain Metastasis Therapeutic Revenue Market Share by Players (2016-2021)
3.2 Global Brain Metastasis Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Brain Metastasis Therapeutic Revenue
3.4 Global Brain Metastasis Therapeutic Market Concentration Ratio
3.4.1 Global Brain Metastasis Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Brain Metastasis Therapeutic Revenue in 2020
3.5 Brain Metastasis Therapeutic Key Players Head office and Area Served
3.6 Key Players Brain Metastasis Therapeutic Product Solution and Service
3.7 Date of Enter into Brain Metastasis Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Brain Metastasis Therapeutic Breakdown Data by Type
4.1 Global Brain Metastasis Therapeutic Historic Market Size by Type (2016-2021)
4.2 Global Brain Metastasis Therapeutic Forecasted Market Size by Type (2022-2027)

5 Brain Metastasis Therapeutic Breakdown Data by Application
5.1 Global Brain Metastasis Therapeutic Historic Market Size by Application (2016-2021)
5.2 Global Brain Metastasis Therapeutic Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Brain Metastasis Therapeutic Market Size (2016-2027)
6.2 North America Brain Metastasis Therapeutic Market Size by Type
6.2.1 North America Brain Metastasis Therapeutic Market Size by Type (2016-2021)
6.2.2 North America Brain Metastasis Therapeutic Market Size by Type (2022-2027)
6.2.3 North America Brain Metastasis Therapeutic Market Size by Type (2016-2027)
6.3 North America Brain Metastasis Therapeutic Market Size by Application
6.3.1 North America Brain Metastasis Therapeutic Market Size by Application (2016-2021)
6.3.2 North America Brain Metastasis Therapeutic Market Size by Application (2022-2027)
6.3.3 North America Brain Metastasis Therapeutic Market Size by Application (2016-2027)
6.4 North America Brain Metastasis Therapeutic Market Size by Country
6.4.1 North America Brain Metastasis Therapeutic Market Size by Country (2016-2021)
6.4.2 North America Brain Metastasis Therapeutic Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Brain Metastasis Therapeutic Market Size (2016-2027)
7.2 Europe Brain Metastasis Therapeutic Market Size by Type
7.2.1 Europe Brain Metastasis Therapeutic Market Size by Type (2016-2021)
7.2.2 Europe Brain Metastasis Therapeutic Market Size by Type (2022-2027)
7.2.3 Europe Brain Metastasis Therapeutic Market Size by Type (2016-2027)
7.3 Europe Brain Metastasis Therapeutic Market Size by Application
7.3.1 Europe Brain Metastasis Therapeutic Market Size by Application (2016-2021)
7.3.2 Europe Brain Metastasis Therapeutic Market Size by Application (2022-2027)
7.3.3 Europe Brain Metastasis Therapeutic Market Size by Application (2016-2027)
7.4 Europe Brain Metastasis Therapeutic Market Size by Country
7.4.1 Europe Brain Metastasis Therapeutic Market Size by Country (2016-2021)
7.4.2 Europe Brain Metastasis Therapeutic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Brain Metastasis Therapeutic Market Size (2016-2027)
8.2 Asia-Pacific Brain Metastasis Therapeutic Market Size by Type
8.2.1 Asia-Pacific Brain Metastasis Therapeutic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Brain Metastasis Therapeutic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Brain Metastasis Therapeutic Market Size by Type (2016-2027)
8.3 Asia-Pacific Brain Metastasis Therapeutic Market Size by Application
8.3.1 Asia-Pacific Brain Metastasis Therapeutic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Brain Metastasis Therapeutic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Brain Metastasis Therapeutic Market Size by Application (2016-2027)
8.4 Asia-Pacific Brain Metastasis Therapeutic Market Size by Region
8.4.1 Asia-Pacific Brain Metastasis Therapeutic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Brain Metastasis Therapeutic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Brain Metastasis Therapeutic Market Size (2016-2027)
9.2 Latin America Brain Metastasis Therapeutic Market Size by Type
9.2.1 Latin America Brain Metastasis Therapeutic Market Size by Type (2016-2021)
9.2.2 Latin America Brain Metastasis Therapeutic Market Size by Type (2022-2027)
9.2.3 Latin America Brain Metastasis Therapeutic Market Size by Type (2016-2027)
9.3 Latin America Brain Metastasis Therapeutic Market Size by Application
9.3.1 Latin America Brain Metastasis Therapeutic Market Size by Application (2016-2021)
9.3.2 Latin America Brain Metastasis Therapeutic Market Size by Application (2022-2027)
9.3.3 Latin America Brain Metastasis Therapeutic Market Size by Application (2016-2027)
9.4 Latin America Brain Metastasis Therapeutic Market Size by Country
9.4.1 Latin America Brain Metastasis Therapeutic Market Size by Country (2016-2021)
9.4.2 Latin America Brain Metastasis Therapeutic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Brain Metastasis Therapeutic Market Size (2016-2027)
10.2 Middle East & Africa Brain Metastasis Therapeutic Market Size by Type
10.2.1 Middle East & Africa Brain Metastasis Therapeutic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Brain Metastasis Therapeutic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Brain Metastasis Therapeutic Market Size by Type (2016-2027)
10.3 Middle East & Africa Brain Metastasis Therapeutic Market Size by Application
10.3.1 Middle East & Africa Brain Metastasis Therapeutic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Brain Metastasis Therapeutic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Brain Metastasis Therapeutic Market Size by Application (2016-2027)
10.4 Middle East & Africa Brain Metastasis Therapeutic Market Size by Country
10.4.1 Middle East & Africa Brain Metastasis Therapeutic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Brain Metastasis Therapeutic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 F. Hoffmann-La Roche Ltd.
11.1.1 F. Hoffmann-La Roche Ltd. Company Details
11.1.2 F. Hoffmann-La Roche Ltd. Business Overview
11.1.3 F. Hoffmann-La Roche Ltd. Brain Metastasis Therapeutic Introduction
11.1.4 F. Hoffmann-La Roche Ltd. Revenue in Brain Metastasis Therapeutic Business (2016-2021)
11.1.5 F. Hoffmann-La Roche Ltd. Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Brain Metastasis Therapeutic Introduction
11.2.4 GlaxoSmithKline Revenue in Brain Metastasis Therapeutic Business (2016-2021)
11.2.5 GlaxoSmithKline Recent Development
11.3 Eli Lilly & Company
11.3.1 Eli Lilly & Company Company Details
11.3.2 Eli Lilly & Company Business Overview
11.3.3 Eli Lilly & Company Brain Metastasis Therapeutic Introduction
11.3.4 Eli Lilly & Company Revenue in Brain Metastasis Therapeutic Business (2016-2021)
11.3.5 Eli Lilly & Company Recent Development
11.4 Merck & Co., Inc.
11.4.1 Merck & Co., Inc. Company Details
11.4.2 Merck & Co., Inc. Business Overview
11.4.3 Merck & Co., Inc. Brain Metastasis Therapeutic Introduction
11.4.4 Merck & Co., Inc. Revenue in Brain Metastasis Therapeutic Business (2016-2021)
11.4.5 Merck & Co., Inc. Recent Development
11.5 Bayer AG
11.5.1 Bayer AG Company Details
11.5.2 Bayer AG Business Overview
11.5.3 Bayer AG Brain Metastasis Therapeutic Introduction
11.5.4 Bayer AG Revenue in Brain Metastasis Therapeutic Business (2016-2021)
11.5.5 Bayer AG Recent Development
11.6 AngioChem Inc.
11.6.1 AngioChem Inc. Company Details
11.6.2 AngioChem Inc. Business Overview
11.6.3 AngioChem Inc. Brain Metastasis Therapeutic Introduction
11.6.4 AngioChem Inc. Revenue in Brain Metastasis Therapeutic Business (2016-2021)
11.6.5 AngioChem Inc. Recent Development
11.7 Novartis AG
11.7.1 Novartis AG Company Details
11.7.2 Novartis AG Business Overview
11.7.3 Novartis AG Brain Metastasis Therapeutic Introduction
11.7.4 Novartis AG Revenue in Brain Metastasis Therapeutic Business (2016-2021)
11.7.5 Novartis AG Recent Development
11.8 Pfizer Inc.
11.8.1 Pfizer Inc. Company Details
11.8.2 Pfizer Inc. Business Overview
11.8.3 Pfizer Inc. Brain Metastasis Therapeutic Introduction
11.8.4 Pfizer Inc. Revenue in Brain Metastasis Therapeutic Business (2016-2021)
11.8.5 Pfizer Inc. Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Brain Metastasis Therapeutic Introduction
11.9.4 AstraZeneca Revenue in Brain Metastasis Therapeutic Business (2016-2021)
11.9.5 AstraZeneca Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Brain Metastasis Therapeutic Introduction
11.10.4 Sanofi Revenue in Brain Metastasis Therapeutic Business (2016-2021)
11.10.5 Sanofi Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Brain Metastasis Therapeutic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Corticosteroids
Table 3. Key Players of Anticonvulsants
Table 4. Key Players of Targeted Therapy
Table 5. Key Players of Chemotherapy
Table 6. Key Players of Radiation Therapy
Table 7. Global Brain Metastasis Therapeutic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Brain Metastasis Therapeutic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Brain Metastasis Therapeutic Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Brain Metastasis Therapeutic Market Share by Regions (2016-2021)
Table 11. Global Brain Metastasis Therapeutic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Brain Metastasis Therapeutic Market Share by Regions (2022-2027)
Table 13. Brain Metastasis Therapeutic Market Trends
Table 14. Brain Metastasis Therapeutic Market Drivers
Table 15. Brain Metastasis Therapeutic Market Challenges
Table 16. Brain Metastasis Therapeutic Market Restraints
Table 17. Global Brain Metastasis Therapeutic Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Brain Metastasis Therapeutic Market Share by Players (2016-2021)
Table 19. Global Top Brain Metastasis Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brain Metastasis Therapeutic as of 2020)
Table 20. Ranking of Global Top Brain Metastasis Therapeutic Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Brain Metastasis Therapeutic Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Brain Metastasis Therapeutic Product Solution and Service
Table 24. Date of Enter into Brain Metastasis Therapeutic Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Brain Metastasis Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Brain Metastasis Therapeutic Revenue Market Share by Type (2016-2021)
Table 28. Global Brain Metastasis Therapeutic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Brain Metastasis Therapeutic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Brain Metastasis Therapeutic Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Brain Metastasis Therapeutic Revenue Market Share by Application (2016-2021)
Table 32. Global Brain Metastasis Therapeutic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Brain Metastasis Therapeutic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Brain Metastasis Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Brain Metastasis Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Brain Metastasis Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Brain Metastasis Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Brain Metastasis Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Brain Metastasis Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Brain Metastasis Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Brain Metastasis Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Brain Metastasis Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Brain Metastasis Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Brain Metastasis Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Brain Metastasis Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Brain Metastasis Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Brain Metastasis Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Brain Metastasis Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Brain Metastasis Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Brain Metastasis Therapeutic Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Brain Metastasis Therapeutic Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Brain Metastasis Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Brain Metastasis Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Brain Metastasis Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Brain Metastasis Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Brain Metastasis Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Brain Metastasis Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Brain Metastasis Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Brain Metastasis Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Brain Metastasis Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Brain Metastasis Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Brain Metastasis Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Brain Metastasis Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 64. F. Hoffmann-La Roche Ltd. Company Details
Table 65. F. Hoffmann-La Roche Ltd. Business Overview
Table 66. F. Hoffmann-La Roche Ltd. Brain Metastasis Therapeutic Product
Table 67. F. Hoffmann-La Roche Ltd. Revenue in Brain Metastasis Therapeutic Business (2016-2021) & (US$ Million)
Table 68. F. Hoffmann-La Roche Ltd. Recent Development
Table 69. GlaxoSmithKline Company Details
Table 70. GlaxoSmithKline Business Overview
Table 71. GlaxoSmithKline Brain Metastasis Therapeutic Product
Table 72. GlaxoSmithKline Revenue in Brain Metastasis Therapeutic Business (2016-2021) & (US$ Million)
Table 73. GlaxoSmithKline Recent Development
Table 74. Eli Lilly & Company Company Details
Table 75. Eli Lilly & Company Business Overview
Table 76. Eli Lilly & Company Brain Metastasis Therapeutic Product
Table 77. Eli Lilly & Company Revenue in Brain Metastasis Therapeutic Business (2016-2021) & (US$ Million)
Table 78. Eli Lilly & Company Recent Development
Table 79. Merck & Co., Inc. Company Details
Table 80. Merck & Co., Inc. Business Overview
Table 81. Merck & Co., Inc. Brain Metastasis Therapeutic Product
Table 82. Merck & Co., Inc. Revenue in Brain Metastasis Therapeutic Business (2016-2021) & (US$ Million)
Table 83. Merck & Co., Inc. Recent Development
Table 84. Bayer AG Company Details
Table 85. Bayer AG Business Overview
Table 86. Bayer AG Brain Metastasis Therapeutic Product
Table 87. Bayer AG Revenue in Brain Metastasis Therapeutic Business (2016-2021) & (US$ Million)
Table 88. Bayer AG Recent Development
Table 89. AngioChem Inc. Company Details
Table 90. AngioChem Inc. Business Overview
Table 91. AngioChem Inc. Brain Metastasis Therapeutic Product
Table 92. AngioChem Inc. Revenue in Brain Metastasis Therapeutic Business (2016-2021) & (US$ Million)
Table 93. AngioChem Inc. Recent Development
Table 94. Novartis AG Company Details
Table 95. Novartis AG Business Overview
Table 96. Novartis AG Brain Metastasis Therapeutic Product
Table 97. Novartis AG Revenue in Brain Metastasis Therapeutic Business (2016-2021) & (US$ Million)
Table 98. Novartis AG Recent Development
Table 99. Pfizer Inc. Company Details
Table 100. Pfizer Inc. Business Overview
Table 101. Pfizer Inc. Revenue in Brain Metastasis Therapeutic Business (2016-2021) & (US$ Million)
Table 102. Pfizer Inc. Recent Development
Table 103. AstraZeneca Company Details
Table 104. AstraZeneca Business Overview
Table 105. AstraZeneca Brain Metastasis Therapeutic Product
Table 106. AstraZeneca Revenue in Brain Metastasis Therapeutic Business (2016-2021) & (US$ Million)
Table 107. AstraZeneca Recent Development
Table 108. Sanofi Company Details
Table 109. Sanofi Business Overview
Table 110. Sanofi Brain Metastasis Therapeutic Product
Table 111. Sanofi Revenue in Brain Metastasis Therapeutic Business (2016-2021) & (US$ Million)
Table 112. Sanofi Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Brain Metastasis Therapeutic Market Share by Type: 2020 VS 2027
Figure 2. Corticosteroids Features
Figure 3. Anticonvulsants Features
Figure 4. Targeted Therapy Features
Figure 5. Chemotherapy Features
Figure 6. Radiation Therapy Features
Figure 7. Global Brain Metastasis Therapeutic Market Share by Application: 2020 VS 2027
Figure 8. Cancer Research Centers Case Studies
Figure 9. Cancer Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Brain Metastasis Therapeutic Report Years Considered
Figure 13. Global Brain Metastasis Therapeutic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Brain Metastasis Therapeutic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Brain Metastasis Therapeutic Market Share by Regions: 2020 VS 2027
Figure 16. Global Brain Metastasis Therapeutic Market Share by Regions (2022-2027)
Figure 17. Global Brain Metastasis Therapeutic Market Share by Players in 2020
Figure 18. Global Top Brain Metastasis Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brain Metastasis Therapeutic as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Brain Metastasis Therapeutic Revenue in 2020
Figure 20. Global Brain Metastasis Therapeutic Revenue Market Share by Type (2016-2021)
Figure 21. Global Brain Metastasis Therapeutic Revenue Market Share by Type (2022-2027)
Figure 22. North America Brain Metastasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Brain Metastasis Therapeutic Market Share by Type (2016-2027)
Figure 24. North America Brain Metastasis Therapeutic Market Share by Application (2016-2027)
Figure 25. North America Brain Metastasis Therapeutic Market Share by Country (2016-2027)
Figure 26. United States Brain Metastasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Brain Metastasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Brain Metastasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Brain Metastasis Therapeutic Market Share by Type (2016-2027)
Figure 30. Europe Brain Metastasis Therapeutic Market Share by Application (2016-2027)
Figure 31. Europe Brain Metastasis Therapeutic Market Share by Country (2016-2027)
Figure 32. Germany Brain Metastasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Brain Metastasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Brain Metastasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Brain Metastasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Brain Metastasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Brain Metastasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Brain Metastasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Brain Metastasis Therapeutic Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Brain Metastasis Therapeutic Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Brain Metastasis Therapeutic Market Share by Region (2016-2027)
Figure 42. China Brain Metastasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Brain Metastasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Brain Metastasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Brain Metastasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Brain Metastasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Brain Metastasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Brain Metastasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Brain Metastasis Therapeutic Market Share by Type (2016-2027)
Figure 50. Latin America Brain Metastasis Therapeutic Market Share by Application (2016-2027)
Figure 51. Latin America Brain Metastasis Therapeutic Market Share by Country (2016-2027)
Figure 52. Mexico Brain Metastasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Brain Metastasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Brain Metastasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Brain Metastasis Therapeutic Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Brain Metastasis Therapeutic Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Brain Metastasis Therapeutic Market Share by Country (2016-2027)
Figure 58. Turkey Brain Metastasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Brain Metastasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Brain Metastasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Brain Metastasis Therapeutic Business (2016-2021)
Figure 62. GlaxoSmithKline Revenue Growth Rate in Brain Metastasis Therapeutic Business (2016-2021)
Figure 63. Eli Lilly & Company Revenue Growth Rate in Brain Metastasis Therapeutic Business (2016-2021)
Figure 64. Merck & Co., Inc. Revenue Growth Rate in Brain Metastasis Therapeutic Business (2016-2021)
Figure 65. Bayer AG Revenue Growth Rate in Brain Metastasis Therapeutic Business (2016-2021)
Figure 66. AngioChem Inc. Revenue Growth Rate in Brain Metastasis Therapeutic Business (2016-2021)
Figure 67. Novartis AG Revenue Growth Rate in Brain Metastasis Therapeutic Business (2016-2021)
Figure 68. Pfizer Inc. Revenue Growth Rate in Brain Metastasis Therapeutic Business (2016-2021)
Figure 69. AstraZeneca Revenue Growth Rate in Brain Metastasis Therapeutic Business (2016-2021)
Figure 70. Sanofi Revenue Growth Rate in Brain Metastasis Therapeutic Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

---